U.S. FDA Eyes Five Global Regions For Permanent Outposts
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is in the early stages of developing "boots on the ground" programs in five regions overseas in an effort to improve the quality of imported products at their source, Commissioner Andrew von Eschenbach said Jan. 24 at a media briefing on food safety issues
You may also be interested in...
Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Von Eschenbach spoke with PharmAsia News about international regulatory collaboration and his vision for the future of the agency.
Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Von Eschenbach spoke with PharmAsia News about international regulatory collaboration and his vision for the future of the agency.
U.S. FDA Move “Beyond Our Borders” Begins With China
Congressional concerns over inspection oversight in the midst of a heparin safety scare have not dampened FDA's efforts to highlight its new overseas initiative, "FDA Beyond Our Borders.